Laurence J. Egan

机构：Health Service Executive, IBM Research - Ireland · ORCID：0000-0002-0142-6340

发表论文 164 篇 · 总被引 9660 次 · h-index 39

代表论文

• Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies (2024 · The Lancet · 被引 95)
• Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment (2023 · Cell Reports · 被引 94)
• I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease (2022 · Clinical Gastroenterology and Hepatology · 被引 38)
• Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling (2024 · iScience · 被引 22)
• The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study (2022 · Journal of Crohn s and Colitis · 被引 14)
• Effectiveness, safety, and cost of combination advanced therapies in inflammatory bowel disease (2024 · Digestive and Liver Disease · 被引 10)